C
Power Law company profile
Corvidia
Biotech & Life Sciences · Waltham, United States · Founded 2015 Unicorn
Patent intelligence
$11M patent portfolio · 4 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$11M
0.52% of valuation · 28.2× smaller than top peer Acceleron Pharma ($309M)
4 active patent families
Where Corvidia innovates
AntagonistPharmacologyInflammationMolecular biologyImmuno suppression
Above peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Corvidia on the five Patsnap quality dimensions
Corvidia in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Corvidia concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Corvidia and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Corvidia on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.